๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4

โœ Scribed by J. F. ROSSIGNOL; S. M. KABIL; Y. EL-GOHARY; A. ELFERT; E. B. KEEFFE


Book ID
108605408
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
106 KB
Volume
28
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Combination therapy with thymosin ฮฑ1 and
โœ Kenneth E. Sherman; Maria Sjogren; Robin L. Creager; Melissa A. Damiano; Stephen ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 111 KB ๐Ÿ‘ 1 views

Hepatitis C is a major cause of liver disease leading to cirrhosis. Although interferon (IFN) is the only approved therapy, treatment is characterized by low response rates and dose-limiting side effects. We evaluated the addition of thymosin โฃ1 (TA1), an immunomodulatory peptide, to the standard tr